Pfizer Inc.

Stocks

Real-time Estimate Cboe BZX 11:33:37 01/09/26 pm AEST			5-day change	1st Jan Change
28.98 ^USD	+1.81%		+1.75%	+14.30%

09:51pm	Global pharma companies that have publicly announced Trump drug pricing agreements	RE
04:40pm	GSK Moves mRNA Flu Vaccine Candidate to Late-Stage Trial	DJ

Published on 06/18/2026 at 05:37 am AEST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good day everyone and welcome to Pfizer Flash Live from ADA, spotlighting berobenatide, an investigational potential first-in-class monthly GLP-1

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

09:51pm	Global pharma companies that have publicly announced Trump drug pricing agreements	RE
04:40pm	GSK Moves mRNA Flu Vaccine Candidate to Late-Stage Trial	DJ
01/09	Trump announces new round of drug-pricing deals	RE
01/09	Donald Trump prepares new agreements to reduce drug prices
01/09	Trump administration to announce drug pricing deals	RE
29/08	BioNTech Terminates Phase 2 Colorectal Cancer Clinical Trial; Shares Fall	MT
29/08	FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax -- Update	DJ
28/08	Global markets live: Nvidia, Marvell, Rivian, Eli Lilly, Moderna…
28/08	Roivant, Priovant launch newly approved rare disease drug Lisraya at $35,000 a month	RE
28/08	Warsh Takes the Stage
28/08	A tale of two markets
28/08	FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech	DJ
28/08	Pfizer, BioNTech Get US FDA Clearance for COVID-19 Vaccine Targeting XFG Variant	MT
28/08	Pfizer And BioNTech Receive U.S. FDA Approval For XFG-Adapted COVID-19 Vaccine	CI
28/08	US FDA approves Roivant-Priovant's skin and muscle disease drug	RE